Drug Efficacy Testing Services in Animal Models of Stroke


Preclinical studies are those conducted using animal experimental models of stroke as well as neurons, cellular neuronal cultures, and surviving brain slices. Animal experiments have contributed greatly to the understanding of the pathophysiology of stroke, and several animal species such as mice, rabbits, and nonhuman primates (NHPs) have been used as models for stroke research. Hundreds of drugs have been preclinically tested in animal models of ischemic stroke and found to be effective in neuroprotection. When it comes to securing scientific evidence of your compound's effectiveness, Ace Therapeutics has you covered.

As a preclinical CRO, Ace Therapeutics offers more than 10+ animal models of stroke to simulate stroke conditions. We not only help our clients to select appropriate in vivo efficacy models but also develop new animal models to conduct relevant drug efficacy testing experiments according to their specific requirements.

We use state-of-the-art technologies (including confocal microscopy, tomography, MRI, etc.) to measure the dynamic changes in the brain during ischemia and reperfusion to assess the efficacy of specific stroke drugs. These methods allow us to provide critical data to ensure comprehensive and reliable results.

Why Choose Our Drug Efficacy Testing Services

  • With our unique workflow and capabilities, we can deliver the data you need to benefit your organization as soon as possible.
  • With our extensive range of customizable animal models of stroke, we can provide one-stop service from modeling to drug efficacy testing.
  • Our extensive analytical assay and assay development expertise enables you to choose the most appropriate method to assess drug efficacy. Through rigorous analytical control assays, we ensure the accuracy and reliability of your data, thus enhancing the credibility of your research.
  • We offer advanced analytical methods to monitor drug response, giving you a complete picture of its effects.

Ace Therapeutics has extensive experience in conducting preclinical drug efficacy testing, using customized animal stroke models to test compounds. We aim to help global pharmaceutical and biotechnology companies accelerate their preclinical stroke drug discovery and development processes. If you are interested in our services, please do not hesitate to contact us!

All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Inquiry Basket